Biogen | BIIB - Ebitda

Prezzo Delle Azioni
192.95
Cambio Giornaliero
1.58 0.83%
Mensile
9.62%
Annuale
53.63%
Q2 Previsione
189.07




Ebitda Cambiamento Data
AbbVie USD 5.37B 1.85B 2025-12
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
ALKERMES USD 80.26M 20.05M 2026-03
Amgen USD 5.14B 775M 2025-12
Bayer EUR 4.45B 2.49B 2026-03
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Gilead Sciences USD 3.02B 1.01B 2025-12
Incyte USD 367.97M 46.53M 2026-03
Merck USD 6.3B 2.09B 2025-12
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.3B 530M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Sanofi EUR 3.31B 3.65B 2026-03
Sanofi EUR 5.66B 3.77B 2025-09
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
United Therapeutics USD 379.5M 83.4M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03